Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Exposure Prophylaxis | 8 | 2024 | 171 | 1.370 |
Why?
|
| HIV Infections | 14 | 2024 | 4946 | 0.750 |
Why?
|
| Anti-HIV Agents | 7 | 2024 | 1275 | 0.650 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2024 | 235 | 0.360 |
Why?
|
| Adaptation, Psychological | 2 | 2019 | 26 | 0.320 |
Why?
|
| Homosexuality, Male | 2 | 2024 | 48 | 0.280 |
Why?
|
| Sexual and Gender Minorities | 2 | 2024 | 28 | 0.280 |
Why?
|
| Social Stigma | 4 | 2024 | 76 | 0.280 |
Why?
|
| Adolescent | 9 | 2024 | 2858 | 0.280 |
Why?
|
| Qualitative Research | 3 | 2024 | 294 | 0.280 |
Why?
|
| Male | 12 | 2024 | 6489 | 0.260 |
Why?
|
| Young Adult | 8 | 2024 | 2357 | 0.250 |
Why?
|
| South Africa | 12 | 2023 | 7312 | 0.230 |
Why?
|
| Adult | 11 | 2024 | 5664 | 0.220 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2023 | 34 | 0.220 |
Why?
|
| Humans | 15 | 2024 | 14077 | 0.210 |
Why?
|
| Female | 12 | 2024 | 8751 | 0.210 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 12 | 0.200 |
Why?
|
| Zimbabwe | 4 | 2023 | 115 | 0.200 |
Why?
|
| Uganda | 4 | 2023 | 194 | 0.200 |
Why?
|
| AIDS Vaccines | 1 | 2022 | 150 | 0.180 |
Why?
|
| HIV | 2 | 2022 | 380 | 0.180 |
Why?
|
| Attitude to Health | 2 | 2021 | 56 | 0.170 |
Why?
|
| Prescription Drug Misuse | 1 | 2019 | 2 | 0.170 |
Why?
|
| Resilience, Psychological | 1 | 2019 | 11 | 0.170 |
Why?
|
| HIV Seropositivity | 1 | 2021 | 263 | 0.160 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 49 | 0.160 |
Why?
|
| Anti-Retroviral Agents | 2 | 2019 | 542 | 0.150 |
Why?
|
| Treatment Refusal | 1 | 2015 | 13 | 0.120 |
Why?
|
| Disclosure | 1 | 2015 | 25 | 0.120 |
Why?
|
| HIV-1 | 2 | 2019 | 1239 | 0.110 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 1377 | 0.100 |
Why?
|
| Sexual Behavior | 2 | 2022 | 313 | 0.090 |
Why?
|
| Logistic Models | 2 | 2019 | 252 | 0.080 |
Why?
|
| Counseling | 2 | 2019 | 136 | 0.080 |
Why?
|
| Social Support | 2 | 2019 | 76 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2019 | 1131 | 0.060 |
Why?
|
| Transgender Persons | 1 | 2024 | 21 | 0.060 |
Why?
|
| Kenya | 1 | 2024 | 173 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 112 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2024 | 190 | 0.060 |
Why?
|
| Africa South of the Sahara | 1 | 2024 | 328 | 0.050 |
Why?
|
| Middle Aged | 2 | 2022 | 3425 | 0.050 |
Why?
|
| Community Participation | 1 | 2022 | 42 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 532 | 0.050 |
Why?
|
| Africa, Southern | 1 | 2022 | 89 | 0.050 |
Why?
|
| Risk-Taking | 1 | 2022 | 119 | 0.050 |
Why?
|
| Heterosexuality | 1 | 2021 | 30 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2022 | 1410 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2019 | 303 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 409 | 0.040 |
Why?
|
| Aged | 1 | 2022 | 1650 | 0.040 |
Why?
|
| Social Isolation | 1 | 2015 | 5 | 0.030 |
Why?
|
| Asymptomatic Infections | 1 | 2015 | 29 | 0.030 |
Why?
|
| Viral Load | 1 | 2019 | 808 | 0.030 |
Why?
|
| Pregnancy | 2 | 2018 | 1815 | 0.030 |
Why?
|
| Pregnancy in Diabetics | 1 | 1987 | 2 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1987 | 25 | 0.020 |
Why?
|
| Blood Glucose | 1 | 1987 | 106 | 0.020 |
Why?
|
| Self Care | 1 | 1987 | 14 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1987 | 20 | 0.000 |
Why?
|
| Insulin | 1 | 1987 | 72 | 0.000 |
Why?
|
| Infant Mortality | 1 | 1987 | 92 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1987 | 132 | 0.000 |
Why?
|